ArticleBriefings in bioinformatics2026
DeOPUS: cellular deconvolution via optimized power-transformed unmixing with shrinkage.
Article in Briefings in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Single-cell RNA sequencing provides high-resolution insights into cellular heterogeneity but its widespread application is often constrained by high costs and technical complexity. Cellular deconvolution serves as a cost-effective alternative by computationally estimating cell-type proportions from bulk RNA-seq data. However, the extreme dynamic range and inherent heteroscedasticity of transcriptomic data pose significant challenges for accurate estimation. Here, we present deconvolution via optimized power-transformed unmixing with shrinkage (DeOPUS), a reference-based deconvolution method that introduces a hierarchical shrinkage transformation (HST) to robustly estimate cellular compositions. DeOPUS integrates multi-level adaptive priors, variance-stabilizing power transformations, and rank-based quantile normalization to mitigate the influence of outliers and high-variance technical noise. We systematically benchmark DeOPUS against eight state-of-the-art methods across 122 tissues and 12 organ systems. DeOPUS consistently outperforms all eight competitors by having mean Pearson ($r = 0.82$) and Spearman ($\rho = 0.77$) correlations. DeOPUS significantly surpasses the second-best method ($r = 0.75, \rho = 0.68$) while maintaining the lowest mean squared error (MSE = 0.007). Notably, DeOPUS ranks first in the vast majority of tissues and organ systems using all three metrics, demonstrating unrivaled robustness to increasing cellular complexity. More in-depth validation on 18 bulk datasets with experimentally determined cell-type proportions further confirms DeOPUS's strong performance. DeOPUS is the sole method to achieve positive correlations across all datasets, and achieves the highest accuracy for dominant cell-type identification. DeOPUS is available as an open-source R package at https://github.com/tinnlab/DeOPUS.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.